Bisdisulizole

Bisdisulizole

SCHEMBL7706777

O=S(=O)(O)c1cc(S(=O)(=O)O)c2[nH]c(-c3ccc(-c4nc5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c5[nH]4)cc3)nc2c1.[Na].[Na]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.49
ADORA2B P29275 6/20 0.44
ADORA2A P29274 4/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
GLA P06280 3/20 0.44
HPGD P15428 3/20 0.44
HSD17B10 Q99714 3/20 0.44
CYP2C19 P33261 3/20 0.44
ADORA3 P0DMS8 2/20 0.44
NFKB1 P19838 1/20 0.44
ADORA1 P30542 1/20 0.44
MEN1 O00255 2/20 0.41
TSHR P16473 2/20 0.41
KMT2A Q03164 2/20 0.41
SCD O00767 3/20 0.40
CYP2D6 P10635 2/20 0.40
ALOX15 P16050 1/20 0.40
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bisdisulizole SCHEMBL7707182 1.00 HDAC6 (0.49) HDAC6ADORA2BADORA2AKDM4EALDH1A1
SCHEMBL18159480 0.93 SCD (0.47) HDAC6ADORA2BADORA2AKDM4EALDH1A1
SCHEMBL7190581 0.93 HDAC6 (0.59) HDAC6ADORA2BADORA2AKDM4EALDH1A1
SCHEMBL25769743 0.92 HDAC6 (0.43) HDAC6ADORA2BADORA2AKDM4EALDH1A1
SCHEMBL15436778 0.91 HDAC6 (0.51) HDAC6ADORA2BADORA2AKDM4EALDH1A1
SCHEMBL15436708 0.90 HDAC6 (0.67) HDAC6CYP2C19SCDCYP2D6CYP3A4
SCHEMBL6566428 0.83 HDAC6 (0.41) HDAC6ADORA2BADORA2AKDM4EALDH1A1
SCHEMBL10608670 0.78 HDAC6 (0.33) HDAC6ALDH1A1HSD17B10CYP2C19CYP2C9
SCHEMBL12866609 0.78 HDAC6 (0.55) HDAC6ADORA2BADORA2AKDM4EALDH1A1
Bisdisulizole SCHEMBL29507102 0.76 HDAC6 (0.52) HDAC6ADORA2BKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6368578-B1 MIXTURE BEIERSDORF AG (DE) 2002-04-09 US disclosed
US-6355230-B2 FOR ULTRAVIOLET-A RADIATION PROTECTION; SOLUBILITY BEIERSDORF AG (DE) 2002-03-12 US disclosed
US-20010026790-A1 Cosmetic and dermatological light protection formulations wirh a content of benzotriazole derivatives and alkyl naphthalates BEIERSDORF AG (DE) 2001-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010026790-A1 Cosmetic and dermatological light protection formulations wirh a content of benzotriazole derivatives and alkyl naphthalates WHR1, WIZ, LBR HDAC6 1445/4885ADORA2B 1167/4885ADORA2A 809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.